IGM Biosciences, Inc. Debt Conversion, Converted Instrument, Amount
IGM Biosciences, Inc. reported Debt Conversion, Converted Instrument, Amount of $20.00 million for the 12-month period ending 2019-12-31, per its 10-K filed 2022-03-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2022-03-29
- IGM Biosciences, Inc. debt conversion, converted instrument, amount for fiscal 2019 was $20.00M.
| Period end | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|
| 2019-12-31 | $20.00M 10-K · filed 2022-03-29 |